Phase I study of MP-201 in healthy volunteers.

Trial Profile

Phase I study of MP-201 in healthy volunteers.

Planning
Phase of Trial: Phase I

Latest Information Update: 05 Oct 2017

At a glance

  • Drugs MP-201 (Primary)
  • Indications Diabetes mellitus; Neurodegenerative disorders; Neuromuscular disorders; Non-alcoholic steatohepatitis; Obesity
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Oct 2017 New trial record
    • 03 Oct 2017 According to a Mitochon Pharmaceuticals media release, this trial is expected to initiate in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top